ColdBlock Technologies Inc. Announces Exclusive Distribution Partnership with Minas y Concentradoras S.A. in Peru
Niagara Falls, Ontario--(Newsfile Corp. - April 22, 2026) - ColdBlock Technologies Inc. (ColdBlock), developer of innovative sample digestion technology, is proud to announce a new partnership with Minas y Concentradoras S.A., a leading laboratory equipment distributor headquartered in Peru. This collaboration marks an important step in ColdBlock's continued expansion in Latin America, bringing its advanced sample digestion solutions to laboratories, researchers, and industry leaders ac
Technologies, Agriculture, Produits chimiques, Mines et métaux
2026-04-22 7:00 AM EDT | ColdBlock Technologies Inc
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development a
Technologies, Produits chimiques, Pharmaceutique
2026-04-13 6:00 PM EDT | Telescope Innovations Corp.
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows
Technologies, Produits chimiques, Pharmaceutique
2026-03-23 8:00 AM EDT | Telescope Innovations Corp.
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries, with established leadership in sampling systems for monitoring chemical and biological processes. The Company is pleased to announce that it has signed a Development and Collaboration Agreemen
Technologies, Produits chimiques, Pharmaceutique
2026-03-16 8:00 AM EDT | Telescope Innovations Corp.
Telescope Strengthens Investor Communications Strategy
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries,has rescoped its previously announced digital marketing agreement dated September 19, 2025, with Gold Standard Media, LLC ("GSM") and its affiliates. In connection with the reduction in scope GSM has refunded the Compan
Technologies, Produits chimiques, Pharmaceutique
2026-03-12 8:30 AM EDT | Telescope Innovations Corp.
Bachem Reports Strong Sales Growth and Sustained High Profitability
Bubendorf, Switzerland--(Newsfile Corp. - March 12, 2026) - Ad hoc announcement pursuant to Art. 53 LR Bachem Reports Strong Sales Growth and Sustained High Profitability Group sales increase to CHF 695.1 million in 2025 (+14.8%, in local currencies +19.2%). EBITDA increases to CHF 214.7 million (+21.8%, in local currencies +32.6%). EBITDA margin lies at 30.9%. Adjusted for one-time effects of CHF 16.1 milli
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-03-12 1:59 AM EDT | Bachem Holding AG
Grafoid Inc. Corporate Update
Kingston, Ontario--(Newsfile Corp. - March 11, 2026) - This corporate update provides shareholders of Grafoid Inc. ("Grafoid" or the "Company"), with a summary of operational activities during the 2025 fiscal year and early 2026. Unless otherwise indicated, the information below reflects management's current expectations and may contain forward-looking statements (see "Forward-Looking Information" below). Corporate Overview During 2025, the Company continued its transi
Aéronautique / défense, Produits chimiques, Services environnementaux, Produits ménagers / de consommation / cosmétiques
2026-03-11 11:14 AM EDT | Purafy Clean Technologies
Purafy and Electromaax Announce Strategic Global Partnership
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - Purafy Clean Technologies, a pioneer in advanced water filtration using graphene-enhanced ultrafiltration and Electromaax, a global innovator in energy-efficient marine and off-grid systems, today announced a strategic partnership to manufacture and distribute next-generation portable water purification solutions worldwide. The partnership will focus on launching and scaling the Purafy Portage portable water
Aéronautique / défense, Produits chimiques, Services environnementaux, Produits ménagers / de consommation / cosmétiques
2026-02-26 10:38 AM EST | Purafy Clean Technologies
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the installation of its second Self-Driving Laboratory ("SDL") at Pfizer, as part of the multi-year agreement between the companies. The installation was completed in January 202
Technologies, Produits chimiques, Pharmaceutique
2026-02-23 8:00 AM EST | Telescope Innovations Corp.
Cerilon GTL ND Enters Into Diesel Offtake Agreement for its North Dakota Gas-to-Liquids Project
Calgary, Alberta--(Newsfile Corp. - February 11, 2026) - Cerilon GTL ND Inc. ("Cerilon") is pleased to announce the signing of a definitive offtake agreement with a large North American fuel supply and logistics provider ("Offtaker") for ultra-low-sulfur diesel from its gas-to-liquids (GTL) project under development in Williams County, North Dakota. Under the agreement, the Offtaker will purchase all of the diesel output from Cerilon's North Dakota facility, subject to customary terms
Technologies, Produits chimiques, Énergie, Énergies de substitution
2026-02-11 10:00 AM EST | Cerilon Inc.
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2025 (Q1). The Company generated revenues of $2.7 million during this period, driven by continued market adoption of its flagship product, DirectI
Technologies, Produits chimiques, Pharmaceutique
2026-01-30 7:28 PM EST | Telescope Innovations Corp.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a leader in Physical AI, Self-Driving Laboratories, and other enabling technology to support autonomous laboratory infrastructure. The Company is pleased to provide an update on the progress of its lithium processing portfolio. Our focus remains on securing a sustainable, on-shore supply of critical battery materials t
Technologies, Produits chimiques, Pharmaceutique
2026-01-27 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Plans Expansion of DirectInject-LC(TM) Technology Ecosystem to Fuel the Physical AI Revolution
Vancouver, British Columbia--(Newsfile Corp. - January 20, 2026) - Telescope Innovations Corp., (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), is a leader in Physical AI, Self-Driving Laboratories, and enabling technology supporting autonomous laboratory infrastructure. The Company is pleased to provide a look at its planned 2026 technology development pipeline, which aligns with its Self-Driving Lab (SDL) architecture for autonomous chemistry R&D. Buildin
Technologies, Produits chimiques, Pharmaceutique
2026-01-20 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI
Vancouver, British Columbia--(Newsfile Corp. - January 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to provide a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI. This update follows the Company's recent successful deployment of a
Technologies, Produits chimiques, Pharmaceutique
2026-01-05 8:00 AM EST | Telescope Innovations Corp.
Telescope Grants Stock Options, RSUs and Settles Debt with Shares
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries announces that it has authorized the grant of incentive stock options (the "Options"), restricted share units (the "RSUs") as well as the issuance of common shares to settle outstanding fees owed to its
Technologies, Produits chimiques, Pharmaceutique
2025-12-31 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, reports financial results for the fiscal year ended August 31, 2025. The Company generated revenues of $5.8 million during this period, with an Adjusted EBITDA loss of $402K (Figure 1). Telescope continues
Technologies, Produits chimiques, Pharmaceutique
2025-12-23 8:00 PM EST | Telescope Innovations Corp.
Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build
Ontario and Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") On December 8, 2025 Biosenta has entered into a Field Test and Research Agreement with Livespace Homes to evaluate the real-world performance of Biosenta's proprietary antimicrobial nanoparticle technology in a residential construction environment. Under the agreement, the nanoparticles will be incorporated into building materials and/or coatings used in two (2) of the four (4)
Biotechnologies, Produits chimiques, Produits ménagers / de consommation / cosmétiques
2025-12-11 2:21 PM EST | Biosenta Inc.
Telescope Innovations Installs Korea's First Self-Driving Lab for Pharma R&D and Education
HIGHLIGHTS Telescope Innovations' installation of Korea's first Self-Driving Lab for pharmaceutical research completed just three weeks after contract signing Project facilitated by collaboration with the Acceleration Consortium (AC) and supported on site by two-time Chemistry Nobel Laureate Prof. Barry Sharpless Successful SDL delivery demonstrates Telescope's growing commercial momentum, positioning Telescope and the AC to expand SDL adoption across phar
Technologies, Produits chimiques, Pharmaceutique
2025-12-09 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers Association
HIGHLIGHTS This installation for Korea's largest biopharma association represents the first Self-Driving Lab ("SDL") for drug development to be deployed in Korea Partnership supports Korea's transition toward automated and digital R&D SDL automates continuous experimental optimization using robotics, analytics, and AI SDLs show expanding commercial relevance across pharma, minerals, energy, agriculture, and chemical
Technologies, Produits chimiques, Pharmaceutique
2025-11-17 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Conditionally Approved for up to $3.36 M in Government Funding to Advance Lithium Processing Technology
Vancouver, British Columbia--(Newsfile Corp. - November 4, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leader in providing intelligent automation platforms and services that accelerate chemical process development. The Company is pleased to announce that two Government of Canada funding streams totalling up to CAD $3.36 M have been formally or conditionally awarded to Telescope to support th
Technologies, Produits chimiques, Pharmaceutique
2025-11-04 11:00 AM EST | Telescope Innovations Corp.